| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $173.1M | — | +26.9% |
| Cost of Revenue | $41.6M | — | +43.3% |
| Gross Profit | $131.6M | — | +22.5% |
| R&D Expense | $69.8M | — | +28.7% |
| SG&A Expense | $25.9M | — | +7.2% |
| Operating Income | -$44.5M | — | -1.6% |
| Pre-tax Income | -$40.0M | — | -25.8% |
| Income Tax | -$3.2M | — | -180.2% |
| Net Income | -$36.9M | — | -3.0% |
| EPS (Basic) | -$0.32 | — | +0.0% |
| EPS (Diluted) | -$0.32 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $179.3M | -11.4% | +17.1% |
| Short-term Investments | $568.2M | -16.6% | +37.1% |
| Accounts Receivable | $156.6M | -35.5% | +26.7% |
| Current Assets | $1.08B | -16.8% | +32.1% |
| Total Assets | $1.63B | -8.8% | +3.6% |
| Current Liabilities | $638.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $55.0M | — | -19.1% |
| Capital Expenditures | $5.0M | — | +112.5% |
| Investing Cash Flow | $63.3M | — | +353.2% |
| Financing Cash Flow | -$141.5M | — | -87.5% |
| Free Cash Flow | $50.1M | — | -23.7% |
| -10.1% |
| Stockholders' Equity | $453.5M | -24.2% | +23.3% |